Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2958341000168113 | Tysabri (natalizumab 300 mg / 15 mL) injection, 1 x 15 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2958351000168110 | Tysabri 300 mg/15 mL injection, 15 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tysabri 300 mg/15 mL injection, 15 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Tysabri 300 mg/15 mL injection, 15 mL vial | Is a | natalizumab 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | ||
| Tysabri 300 mg/15 mL injection, 15 mL vial | has TPUU | Tysabri 300 mg/15 mL injection, 15 mL vial | true | Inferred relationship | Some | 1 | |
| Tysabri 300 mg/15 mL injection, 15 mL vial | has TP | Tysabri | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tysabri 300 mg/15 mL injection, 15 mL vial | Is a | True | Tysabri 300 mg/15 mL injection, 15 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR